{
    "abstract": "Poxviruses are complex dsDNA viruses with over 200 genes, many of them with unknown role in the stimulation of immune responses. Among these, the vaccinia virus (VACV) L3L ORF encodes an essential protein for the transcription of the VACV early genes. To the best of our knowledge, the immune response elicited by L3 has not been characterized. In this regard, our data describes a DNA L3-coding plasmid (pL3L) that stimulates both, humoral- and cell-mediated immune responses in a mouse model. Cell-mediated immune responses were measured by IFN-\u03b3 and IL-4 ELISPOT assays. We performed CD8+ cells depletion and flow cytometry analysis to account for the contribution of cytotoxic T lymphocytes in the IFN-\u03b3 production. Moreover, results from ELISPOT were confirmed by measuring the concentration of IL-4 and IFN-\u03b3 in supernatant of antigen-stimulated splenocytes by cytokine ELISA. Additionally, dominant antigenic regions of L3 protein were identified by epitope mapping analysis. Humoral immune responses were assessed by ELISA. Specifically, the production of total IgG, IgG1 (TH-2) and IgG2a (TH-1) were determined one week after the final immunization. Our ELISPOT data shows pL3L-immunized animals to produce significantly higher frequencies of IFN-\u03b3 Spot-Forming Cells (SFC) versus controls. IL-4 levels remained unchanged in all three groups, demonstrating the increase in antigen-specific IFN-\u03b3 releasing cells. Flow cytometry assay results showed that CD8+ T cells are a major contributor to the production of IFN-\u03b3. Moreover, our formulation enhances the production of total IgG, predominantly IgG2a isotype. Immunization with pL3L promotes a robust cytotoxic immune response, crucial against viral pathogens. In addition, our vaccine candidate promotes an increase in IgG levels, especially IgG2a (TH-1 type). Our data encourages further studies of L3 as a novel antigen in vaccine development against poxviruses.",
    "author_highlights": [
        {
            "endOffset": 16249,
            "sentence": "Administration of pL3L as naked DNA promotes strong antigen-specific type II IFN response.",
            "startOffset": 16159
        },
        {
            "endOffset": 16330,
            "sentence": "CD8+ T cells are a major contributor to IFN-\u03b3 production in mice receiving pL3L.",
            "startOffset": 16250
        },
        {
            "endOffset": 16396,
            "sentence": "Our formulation does not promote antigen-specific IL-4 secretion.",
            "startOffset": 16331
        },
        {
            "endOffset": 16489,
            "sentence": "Animals immunized with pL3L have significantly higher IgG levels compared to control groups.",
            "startOffset": 16397
        },
        {
            "endOffset": 16559,
            "sentence": "Opsonizing (IgG2a) is the predominant isotype in experimental groups.",
            "startOffset": 16490
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Arban",
                    "initial": "A.",
                    "last": "Domi"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Moss"
                }
            ],
            "doi": "10.1073/pnas.192420599",
            "firstpage": "12415",
            "issn": "00278424",
            "lastpage": "12420",
            "pmid": "12196634",
            "pub_year": 2002,
            "title": "Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells",
            "volume": "99"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Austin L.",
                    "initial": "A.L.",
                    "last": "Hughes"
                },
                {
                    "first": "Stephanie",
                    "initial": "S.",
                    "last": "Irausquin"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Friedman"
                }
            ],
            "doi": "10.1016/j.meegid.2009.10.001",
            "firstpage": "50",
            "issn": "15671348",
            "lastpage": "59",
            "pmid": "19833230",
            "pub_year": 2010,
            "title": "The evolutionary biology of poxviruses",
            "volume": "10"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Scott J.",
                    "initial": "S.J.",
                    "last": "Goebel"
                },
                {
                    "first": "Gerard P.",
                    "initial": "G.P.",
                    "last": "Johnson"
                },
                {
                    "first": "Marion E.",
                    "initial": "M.E.",
                    "last": "Perkus"
                },
                {
                    "first": "Stephen W.",
                    "initial": "S.W.",
                    "last": "Davis"
                },
                {
                    "first": "Joseph P.",
                    "initial": "J.P.",
                    "last": "Winslow"
                },
                {
                    "first": "Enzo",
                    "initial": "E.",
                    "last": "Paoletti"
                }
            ],
            "doi": "10.1016/0042-6822(90)90294-2",
            "firstpage": "247",
            "issn": "00426822",
            "lastpage": "266",
            "pmid": "2219722",
            "pub_year": 1990,
            "title": "The complete DNA sequence of vaccinia virus",
            "volume": "179"
        },
        "b0020": null,
        "b0025": {
            "authors": [
                {
                    "first": "Melanie",
                    "initial": "M.",
                    "last": "Schmid"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Speiseder"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Dobner"
                },
                {
                    "first": "Ramon A.",
                    "initial": "R.A.",
                    "last": "Gonzalez"
                }
            ],
            "doi": "10.1128/JVI.02046-13",
            "firstpage": "1404",
            "issn": "0022538X",
            "lastpage": "1420",
            "pmid": "24257611",
            "pub_year": 2014,
            "title": "DNA virus replication compartments",
            "volume": "88"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Sergei N.",
                    "initial": "S.N.",
                    "last": "Shchelkunov"
                }
            ],
            "doi": "10.1371/journal.ppat.1003756",
            "firstpage": "1",
            "issn": "15537366",
            "lastpage": "4",
            "pmid": "24339772",
            "pub_year": 2013,
            "title": "An Increasing Danger of Zoonotic Orthopoxvirus Infections",
            "volume": "9"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Donald K.",
                    "initial": "D.K.",
                    "last": "Milton"
                }
            ],
            "firstpage": "150",
            "issn": "22352988",
            "pmid": "23226686",
            "pub_year": 2012,
            "title": "What was the primary mode of smallpox transmission? Implications for biodefense.",
            "volume": "2"
        },
        "b0040": null,
        "b0045": {
            "authors": [
                {
                    "first": "J. D.",
                    "initial": "J.D.",
                    "last": "Oriel"
                }
            ],
            "doi": "10.1136/bmj.294.6564.74",
            "firstpage": "74",
            "issn": "02670623",
            "pmid": "3105661",
            "pub_year": 1987,
            "title": "The increase in molluscum contagiosum",
            "volume": "294"
        },
        "b0050": {
            "authors": [
                {
                    "first": "C. A.",
                    "initial": "C.A.",
                    "last": "Mims"
                }
            ],
            "doi": "10.1128/mmbr.45.2.267-286.1981",
            "firstpage": "267",
            "issn": "01460749",
            "lastpage": "286",
            "pmid": "6790919",
            "pub_year": 1981,
            "title": "Vertical transmission of viruses",
            "volume": "45"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Richard N.",
                    "initial": "R.N.",
                    "last": "Greenberg"
                },
                {
                    "first": "Jeffrey S.",
                    "initial": "J.S.",
                    "last": "Kennedy"
                }
            ],
            "doi": "10.1517/13543784.17.4.555",
            "firstpage": "555",
            "issn": "13543784",
            "lastpage": "564",
            "pmid": "18363519",
            "pub_year": 2008,
            "title": "ACAM2000: A newly licensed cell culture-based live vaccinia smallpox vaccine",
            "volume": "17"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Aysegul",
                    "initial": "A.",
                    "last": "Nalca"
                },
                {
                    "first": "Elizabeth E.",
                    "initial": "E.E.",
                    "last": "Zumbrun"
                }
            ],
            "doi": "10.2147/dddt.s3687",
            "firstpage": "71",
            "issn": "11778881",
            "lastpage": "79",
            "pmid": "20531961",
            "pub_year": 2010,
            "title": "ACAM2000\u2122: The new smallpox vaccine for United States Strategic National Stockpile",
            "volume": "4"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Benjamin",
                    "initial": "B.",
                    "last": "Schwartz"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Lebwohl"
                }
            ],
            "doi": "10.1111/j.1365-4632.2004.02568.x",
            "firstpage": "289",
            "issn": "00119059",
            "lastpage": "292",
            "pmid": "15811079",
            "pub_year": 2005,
            "title": "Complications of the smallpox vaccine",
            "volume": "44"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Thomas M.",
                    "initial": "T.M.",
                    "last": "Beachkofsky"
                },
                {
                    "first": "Scott C.",
                    "initial": "S.C.",
                    "last": "Carrizales"
                },
                {
                    "first": "Jeffrey J.",
                    "initial": "J.J.",
                    "last": "Bidinger"
                },
                {
                    "first": "David E.",
                    "initial": "D.E.",
                    "last": "Hrncir"
                },
                {
                    "first": "Darren E.",
                    "initial": "D.E.",
                    "last": "Whittemore"
                },
                {
                    "first": "Chad M.",
                    "initial": "C.M.",
                    "last": "Hivnor"
                }
            ],
            "doi": "10.1001/archdermatol.2010.46",
            "firstpage": "656",
            "issn": "0003987X",
            "lastpage": "661",
            "pmid": "20566929",
            "pub_year": 2010,
            "title": "Adverse events following smallpox vaccination with ACAM2000 in a military population",
            "volume": "146"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Jennifer D.",
                    "initial": "J.D.",
                    "last": "Yoder"
                },
                {
                    "first": "Tsefang S.",
                    "initial": "T.S.",
                    "last": "Chen"
                },
                {
                    "first": "Cliff R.",
                    "initial": "C.R.",
                    "last": "Gagnier"
                },
                {
                    "first": "Srilakshmi",
                    "initial": "S.",
                    "last": "Vemulapalli"
                },
                {
                    "first": "Claudia S.",
                    "initial": "C.S.",
                    "last": "Maier"
                },
                {
                    "first": "Dennis E.",
                    "initial": "D.E.",
                    "last": "Hruby"
                }
            ],
            "doi": "10.1186/1743-422X-3-10",
            "issn": "1743422X",
            "pmid": "16509968",
            "pub_year": 2006,
            "title": "Pox proteomics: Mass spectrometry analysis and identification of Vaccinia virion proteins",
            "volume": "3"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Wolfgang",
                    "initial": "W.",
                    "last": "Resch"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Moss"
                }
            ],
            "doi": "10.1128/JVI.79.23.14719-14729.2005",
            "firstpage": "14719",
            "issn": "0022538X",
            "lastpage": "14729",
            "pmid": "16282472",
            "pub_year": 2005,
            "title": "The conserved poxvirus L3 virion protein is required for transcription of vaccinia virus early genes",
            "volume": "79"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Osmarie",
                    "initial": "O.",
                    "last": "Mart\u00ednez"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Miranda"
                },
                {
                    "first": "Maite",
                    "initial": "M.",
                    "last": "Ram\u00edrez"
                },
                {
                    "first": "Saritza",
                    "initial": "S.",
                    "last": "Santos"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Rivera"
                },
                {
                    "first": "Luis",
                    "initial": "L.",
                    "last": "V\u00e1zquez"
                },
                {
                    "first": "Tom\u00e1s",
                    "initial": "T.",
                    "last": "S\u00e1nchez"
                },
                {
                    "first": "Raymond L.",
                    "initial": "R.L.",
                    "last": "Tremblay"
                },
                {
                    "first": "Eddy",
                    "initial": "E.",
                    "last": "R\u00edos-Olivares"
                },
                {
                    "first": "Miguel",
                    "initial": "M.",
                    "last": "Otero"
                }
            ],
            "doi": "10.1371/journal.pone.0123113",
            "issn": "19326203",
            "pmid": "25875833",
            "pub_year": 2015,
            "title": "Immunomodulator-based enhancement of anti smallpox immune responses",
            "volume": "10"
        },
        "b0090": null,
        "b0095": {
            "authors": [
                {
                    "first": "Danielle M.",
                    "initial": "D.M.",
                    "last": "Tack"
                },
                {
                    "first": "Mary G.",
                    "initial": "M.G.",
                    "last": "Reynolds"
                }
            ],
            "doi": "10.3390/ani1040377",
            "firstpage": "377",
            "issn": "20762615",
            "lastpage": "395",
            "pub_year": 2011,
            "title": "Zoonotic poxviruses associated with companion animals",
            "volume": "1"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Donald A.",
                    "initial": "D.A.",
                    "last": "Henderson"
                },
                {
                    "first": "Thomas V.",
                    "initial": "T.V.",
                    "last": "Inglesby"
                },
                {
                    "first": "John G.",
                    "initial": "J.G.",
                    "last": "Bartlett"
                },
                {
                    "first": "Michael S.",
                    "initial": "M.S.",
                    "last": "Ascher"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Eitzen"
                },
                {
                    "first": "Peter B.",
                    "initial": "P.B.",
                    "last": "Jahrling"
                },
                {
                    "first": "Jerome",
                    "initial": "J.",
                    "last": "Hauer"
                },
                {
                    "first": "Marcelle",
                    "initial": "M.",
                    "last": "Layton"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "McDade"
                },
                {
                    "first": "Michael T.",
                    "initial": "M.T.",
                    "last": "Osterholm"
                },
                {
                    "first": "Tara",
                    "initial": "T.",
                    "last": "O'Toole"
                },
                {
                    "first": "Gerald",
                    "initial": "G.",
                    "last": "Parker"
                },
                {
                    "first": "Trish",
                    "initial": "T.",
                    "last": "Perl"
                },
                {
                    "first": "Philip K.",
                    "initial": "P.K.",
                    "last": "Russell"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Tonat"
                }
            ],
            "doi": "10.1001/jama.281.22.2127",
            "firstpage": "2127",
            "issn": "00987484",
            "lastpage": "2137",
            "pmid": "10367824",
            "pub_year": 1999,
            "title": "Smallpox as a biological weapon: Medical and public health management",
            "volume": "281"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Joel G.",
                    "initial": "J.G.",
                    "last": "Breman"
                },
                {
                    "first": "D. A.",
                    "initial": "D.A.",
                    "last": "Henderson"
                }
            ],
            "doi": "10.1056/NEJMra020025",
            "firstpage": "1300",
            "issn": "00284793",
            "lastpage": "1308",
            "pmid": "11923491",
            "pub_year": 2002,
            "title": "Diagnosis and management of smallpox",
            "volume": "346"
        },
        "b0110": {
            "authors": [
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Varghese"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Curran"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Bunge"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Vroling"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "van Kessel"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Guignard"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Casabona"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Olivieri"
                }
            ],
            "doi": "10.1016/j.puhe.2016.10.013",
            "firstpage": "46",
            "issn": "00333506",
            "lastpage": "49",
            "pmid": "28057197",
            "pub_year": 2017,
            "title": "Contraindication of live vaccines in immunocompromised patients: an estimate of the number of affected people in the USA and the UK",
            "volume": "142"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Jamie R.",
                    "initial": "J.R.",
                    "last": "Schoenborn"
                },
                {
                    "first": "Christopher B.",
                    "initial": "C.B.",
                    "last": "Wilson"
                }
            ],
            "doi": "10.1016/S0065-2776(07)96002-2",
            "firstpage": "41",
            "issn": "00652776",
            "lastpage": "101",
            "pmid": "17981204",
            "pub_year": 2007,
            "title": "Regulation of Interferon-\u03b3 During Innate and Adaptive Immune Responses",
            "volume": "96"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Leonardo K.",
                    "initial": "L.K.",
                    "last": "Teixeira"
                },
                {
                    "first": "Bruna P.F.",
                    "initial": "B.P.F.",
                    "last": "Fonseca"
                },
                {
                    "first": "Bianca A.",
                    "initial": "B.A.",
                    "last": "Barboza"
                },
                {
                    "first": "Jo\u00e3o P.B.",
                    "initial": "J.P.B.",
                    "last": "Viola"
                }
            ],
            "doi": "10.1590/S0074-02762005000900024",
            "firstpage": "137",
            "issn": "00740276",
            "lastpage": "144",
            "pmid": "15962113",
            "pub_year": 2005,
            "title": "The role of interferon-\u03b3 on immune and allergic responses",
            "volume": "100"
        },
        "b0125": {
            "authors": [
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Choi"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Reiser"
                }
            ],
            "doi": "10.1046/j.1365-2249.1998.00690.x",
            "firstpage": "317",
            "issn": "00099104",
            "lastpage": "319",
            "pmid": "9737656",
            "pub_year": 1998,
            "title": "IL-4: Role in disease and regulation of production",
            "volume": "113"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Koup"
                },
                {
                    "first": "Daniel C.",
                    "initial": "D.C.",
                    "last": "Douek"
                }
            ],
            "doi": "10.1101/cshperspect.a007252",
            "issn": "21571422",
            "pmid": "22229122",
            "pub_year": 2011,
            "title": "Vaccine design for CD8 T lymphocyte responses",
            "volume": "1"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Persephone",
                    "initial": "P.",
                    "last": "Borrow"
                },
                {
                    "first": "Hanna",
                    "initial": "H.",
                    "last": "Lewicki"
                },
                {
                    "first": "Beatrice H.",
                    "initial": "B.H.",
                    "last": "Hahn"
                },
                {
                    "first": "George M.",
                    "initial": "G.M.",
                    "last": "Shaw"
                },
                {
                    "first": "Michael B.A.",
                    "initial": "M.B.A.",
                    "last": "Oldstone"
                }
            ],
            "firstpage": "6103",
            "issn": "0022538X",
            "lastpage": "6110",
            "pmid": "8057491",
            "pub_year": 1994,
            "title": "Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection",
            "volume": "68"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Gunasegaran",
                    "initial": "G.",
                    "last": "Karupiah"
                },
                {
                    "first": "R. Mark L.",
                    "initial": "R.M.L.",
                    "last": "Buller"
                },
                {
                    "first": "Nico",
                    "initial": "N.",
                    "last": "Van Rooijen"
                },
                {
                    "first": "Cornelio J.",
                    "initial": "C.J.",
                    "last": "Duarte"
                },
                {
                    "first": "Jianhe",
                    "initial": "J.",
                    "last": "Chen"
                }
            ],
            "firstpage": "8301",
            "issn": "0022538X",
            "lastpage": "8309",
            "pmid": "8970949",
            "pub_year": 1996,
            "title": "Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection",
            "volume": "70"
        },
        "b0145": {
            "authors": [
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Goulding"
                },
                {
                    "first": "Rebecka",
                    "initial": "R.",
                    "last": "Bogue"
                },
                {
                    "first": "Vikas",
                    "initial": "V.",
                    "last": "Tahiliani"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Croft"
                },
                {
                    "first": "Shahram",
                    "initial": "S.",
                    "last": "Salek-Ardakani"
                }
            ],
            "doi": "10.4049/jimmunol.1200799",
            "firstpage": "2432",
            "issn": "00221767",
            "lastpage": "2440",
            "pmid": "22826318",
            "pub_year": 2012,
            "title": "CD8 T cells are essential for recovery from a respiratory vaccinia virus infection",
            "volume": "189"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Harry W.",
                    "initial": "H.W.",
                    "last": "Schroeder"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Cavacini"
                }
            ],
            "doi": "10.1016/j.jaci.2009.09.046",
            "firstpage": "S41",
            "issn": "00916749",
            "lastpage": "S52",
            "pmid": "20176268",
            "pub_year": 2010,
            "title": "Structure and function of immunoglobulins",
            "volume": "125"
        }
    },
    "body_text": [
        {
            "endOffset": 23649,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Concanavalin A (Con A, 5 \u00b5g/mL; Sigma-Aldrich, St. Louis MO, USA) and RPMI were used as a positive and negative controls, respectively.",
            "startOffset": 23514,
            "title": "IFN-\u03b3 and IL-4 ELISPOT"
        },
        {
            "endOffset": 22374,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Plasmids were formulated at a concentration of 1.0 \u03bcg/\u03bcL of DNA in a 150 mM sodium citrate buffer and 0.25% Bupivacaine.",
            "startOffset": 22254,
            "title": "Study design"
        },
        {
            "endOffset": 36302,
            "parents": [],
            "secId": "s0120",
            "sentence": "However, additional studies are required in order to determine the efficacy in protection of this prototype vaccine.",
            "startOffset": 36186,
            "title": "Discussion"
        },
        {
            "endOffset": 18643,
            "parents": [],
            "secId": "s0005",
            "sentence": "Poxviruses are one of the most complex and biggest families of viruses.",
            "startOffset": 18572,
            "title": "Introduction"
        },
        {
            "endOffset": 34092,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0110",
            "sentence": "Moreover, the levels of IgG2a in sera were 6.6-times higher compared to IgG1, demonstrating the predominance of this isotype.",
            "startOffset": 33967,
            "title": "Antibody isotyping"
        },
        {
            "endOffset": 37983,
            "parents": [],
            "secId": "s0120",
            "sentence": "Furthermore, we determined the efficacy of pL3L in stimulating antibody production.",
            "startOffset": 37900,
            "title": "Discussion"
        },
        {
            "endOffset": 30420,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Mean frequencies of Spot-Forming Cells (SFC) per million splenocytes were 459.1 \u00b1 59.6, 98.9 \u00b1 37.0 and 9.6 \u00b1 4.1 (ANOVA test, KWT = 29.77, p < 0.0001), for mice immunized with pL3L, pVax1, and na\u00efve, respectively (Fig. 1A).",
            "startOffset": 30196,
            "title": "VVWR L3-specific IFN-\u03b3 and IL-4 responses"
        },
        {
            "endOffset": 36185,
            "parents": [],
            "secId": "s0120",
            "sentence": "The presented work was directed to study the immune potential of a novel poxviral protein.",
            "startOffset": 36095,
            "title": "Discussion"
        },
        {
            "endOffset": 20256,
            "parents": [],
            "refoffsets": {
                "b0075": {
                    "endOffset": 20146,
                    "startOffset": 20142
                },
                "b0080": {
                    "endOffset": 20255,
                    "startOffset": 20251
                }
            },
            "secId": "s0005",
            "sentence": "L3L encodes for a 40.6 kDa protein [15], consisting of 350 amino acids and expressed in late kinetics, that is conserved in all orthopoxviruses [16].",
            "startOffset": 20107,
            "title": "Introduction"
        },
        {
            "endOffset": 37900,
            "parents": [],
            "secId": "s0120",
            "sentence": "Our results show that when the amount of CD8+ T cells present in the ELISPOT plate decrease to less than 20%, there is a corresponding drop in the Spot Forming Cells per million Splenocytes producing IFN-\u03b3.",
            "startOffset": 37694,
            "title": "Discussion"
        },
        {
            "endOffset": 31857,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "This data demonstrates a correlation between IFN-\u03b3 production and CD8+ lymphocytes, suggesting they play a pivotal role in the cytokine production.",
            "startOffset": 31710,
            "title": "Contribution of CD8+ T cells in IFN-\u03b3 production"
        },
        {
            "endOffset": 21294,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Purification was assessed using the PureLink HiPure GigaPrep Kit following the manufacturer\u2019s instructions (Life Technologies, Carlsbad, USA).",
            "startOffset": 21152,
            "title": "Plasmid propagation and purification"
        },
        {
            "endOffset": 25696,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Labeling was performed at 4 \u00b0C, for 20 min in dark.",
            "startOffset": 25645,
            "title": "Flow cytometry analysis"
        },
        {
            "endOffset": 37029,
            "parents": [],
            "secId": "s0120",
            "sentence": "We used depletion experiments to demonstrate that the L3L-specific IFN-\u03b3 response is mediated through CD3+/CD8+ lymphocytes.",
            "startOffset": 36905,
            "title": "Discussion"
        },
        {
            "endOffset": 26893,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0060",
            "sentence": "The stimulating peptides inducing a significant increase in the frequency of Spot Forming Cells (SFC) per million splenocytes from immunized mice compared to controls were considered dominant.",
            "startOffset": 26701,
            "title": "L3 immunodominant epitopes"
        },
        {
            "endOffset": 28125,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Samples were incubated at room temperature for sixty minutes in secondary antibody diluted at 1:2,500.",
            "startOffset": 28023,
            "title": "Total IgG and antibody isotyping ELISA"
        },
        {
            "endOffset": 29618,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Moreover, sequencing analysis and assembly with a bioinformatics software confirmed the sequence.",
            "startOffset": 29521,
            "title": "Restriction enzyme digestion of pL3L"
        },
        {
            "endOffset": 25797,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "After incubation, FACS staining buffer was added and cells were harvested under the same conditions.",
            "startOffset": 25697,
            "title": "Flow cytometry analysis"
        },
        {
            "endOffset": 20391,
            "parents": [],
            "secId": "s0005",
            "sentence": "However, its role at eliciting an immune response remains unidentified.",
            "startOffset": 20320,
            "title": "Introduction"
        },
        {
            "endOffset": 23013,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "L3 peptides were diluted in RPMI at a concentration of 0.5 mg/mL and stored at \u221220 \u00b0C.",
            "startOffset": 22927,
            "title": "Synthetic peptides"
        },
        {
            "endOffset": 29198,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0075",
            "sentence": "For the depletion assay, the nonparametric Wilcoxon matched-pairs signed rank test was applied.",
            "startOffset": 29103,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 25305,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Cells were labeled with an antibody cocktail containing: murine anti-CD3-FITC (clone 145-2C11) from BD Biosciences (San Jose, CA, USA) and anti-CD8-PerCP/Cy5.5 (clone 53-6.7) from BioLegend (San Diego, CA, USA).",
            "startOffset": 25094,
            "title": "Flow cytometry analysis"
        },
        {
            "endOffset": 28022,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Plates were washed after incubation, and HRP-conjugated goat anti-murine IgG, or IgG1, or IgG2a antibodies (Jackson Immunoresearch, West Grove, PA, USA) were diluted in ChonBlock detection antibody dilution buffer (Chondrex, Redmond, WA, USA).",
            "startOffset": 27779,
            "title": "Total IgG and antibody isotyping ELISA"
        },
        {
            "endOffset": 30649,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "In the case of IL-4 stimulation induced by our vaccine formulation, pL3L, pVAX1 and na\u00efve immunized groups showed mean frequencies of 517.8 \u00b1 45.83, 462.2 \u00b1 24.5, 497.2 \u00b1 50.0 SFC per million splenocytes, respectively (Fig. 1B).",
            "startOffset": 30421,
            "title": "VVWR L3-specific IFN-\u03b3 and IL-4 responses"
        },
        {
            "endOffset": 31308,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "The mean frequency of Spot-Forming Cells (SFC) per million splenocytes was 84.74 \u00b1 25.9 for the CD8+-depleted groups versus 459.1 \u00b1 59.6 from non-depleted samples (Fig. 2A) (Wilcoxon matched-pairs signed rank test, W = \u2212157, p < 0.0001).",
            "startOffset": 31071,
            "title": "Contribution of CD8+ T cells in IFN-\u03b3 production"
        },
        {
            "endOffset": 21807,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Female 4\u20136-week-old BALB/c mice were acquired from Charles River (Wilmington, MA, USA).",
            "startOffset": 21720,
            "title": "Mice"
        },
        {
            "endOffset": 28768,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0075",
            "sentence": "Experimental data was obtained for at least three replicates of each immunization study.",
            "startOffset": 28680,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 21151,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Plasmids were propagated in TOP10 E. coli cells (Invitrogen, Valencia, CA, USA).",
            "startOffset": 21071,
            "title": "Plasmid propagation and purification"
        },
        {
            "endOffset": 19221,
            "parents": [],
            "secId": "s0005",
            "sentence": "Infections with these agents are usually presented with a generalized rash, which is highly infectious.",
            "startOffset": 19118,
            "title": "Introduction"
        },
        {
            "endOffset": 36533,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 36481,
                    "startOffset": 36474
                },
                "b0120": {
                    "endOffset": 36481,
                    "startOffset": 36474
                }
            },
            "secId": "s0120",
            "sentence": "IFN-\u03b3 is the cytokine responsible for activating na\u00efve T cells into TH-1 effectors [23,24], which is crucial to fight intracellular pathogens.",
            "startOffset": 36391,
            "title": "Discussion"
        },
        {
            "endOffset": 25893,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Examination was assessed with BD FACSCalibur cell analyzer (BD Biosciences, San Jose, CA, USA).",
            "startOffset": 25798,
            "title": "Flow cytometry analysis"
        },
        {
            "endOffset": 25441,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Briefly, pools of splenocytes from each individual group were plated in a 96-round bottom plate at a concentration of 1 \u00d7 106 cells/mL.",
            "startOffset": 25306,
            "title": "Flow cytometry analysis"
        },
        {
            "endOffset": 28656,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0070",
            "sentence": "All the tests were carried out in strict accordance with The National Institute of Health guidelines for animal care.",
            "startOffset": 28539,
            "title": "Compliance with ethical standards"
        },
        {
            "endOffset": 30735,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "There was no statistical difference among them (ANOVA test, KWT = 1.045, p = 0.5930).",
            "startOffset": 30650,
            "title": "VVWR L3-specific IFN-\u03b3 and IL-4 responses"
        },
        {
            "endOffset": 25961,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Results were analyzed using FlowJo software (Ashland, Oregon, USA).",
            "startOffset": 25894,
            "title": "Flow cytometry analysis"
        },
        {
            "endOffset": 22829,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The peptides used in this work were derived from the sequence of the VVWR L3 protein and synthesized as 11-mer overlapped 15-mer peptides by JPT Peptide Technologies (Berlin, Germany).",
            "startOffset": 22645,
            "title": "Synthetic peptides"
        },
        {
            "endOffset": 26594,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Individual 15-mer peptides from VVWR L3L antigens were used as specific stimulators in an ELISPOT assay designed to identify the immunodominant regions.",
            "startOffset": 26442,
            "title": "L3 immunodominant epitopes"
        },
        {
            "endOffset": 35293,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "Moreover, in-silico analysis using a computer algorithm showed the region NLPQSCYL to produce the higher score (24.000), among the L3 protein.",
            "startOffset": 35151,
            "title": "L3 immunodominant epitopes"
        },
        {
            "endOffset": 21605,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Characterization of purified pVAX1 and pL3L plasmids was assessed by enzymatic digestion using XhoI and BamHI (New England Biolabs, Ipswich, MA, USA), and DNA sequencing analysis (Davis Sequencing, Davis, CA, USA).",
            "startOffset": 21391,
            "title": "Plasmid propagation and purification"
        },
        {
            "endOffset": 23513,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Plates were blocked with 1% BSA for 2 h. Then, 2 \u00d7 105 splenocytes per well were seeded in RPMI, and stimulated overnight (for IFN-\u03b3) and 48 h (for IL-4) at 37 \u00b0C, in 5% CO2 with the VVWR L3 peptide-mix (JPT Peptide Technologies, Berlin, Germany).",
            "startOffset": 23266,
            "title": "IFN-\u03b3 and IL-4 ELISPOT"
        },
        {
            "endOffset": 35991,
            "parents": [],
            "secId": "s0120",
            "sentence": "In the eventuality of exposure to any poxvirus, this group is highly vulnerable to infection, further jeopardizing their well-being.",
            "startOffset": 35859,
            "title": "Discussion"
        },
        {
            "endOffset": 37585,
            "parents": [],
            "refoffsets": {
                "b0145": {
                    "endOffset": 37584,
                    "startOffset": 37580
                }
            },
            "secId": "s0120",
            "sentence": "Additionally, CD8+ T cells-deficient vaccinia virus-infected mice present severe cachexia, pulmonary inflammation, viral dissemination, and 100% mortality [29].",
            "startOffset": 37425,
            "title": "Discussion"
        },
        {
            "endOffset": 26361,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Optical density was measured at 450 nm in a microplate reader.",
            "startOffset": 26299,
            "title": "Cytokine concentration in cell supernatant"
        },
        {
            "endOffset": 27778,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Serum samples were diluted at 1:50 in ChonBlock and incubated for two additional hours at room temperature.",
            "startOffset": 27671,
            "title": "Total IgG and antibody isotyping ELISA"
        },
        {
            "endOffset": 35150,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "Stimulation with these peptides showed a significant increase (ANOVA test, KWT = 237.3, p < 0.0001) in the frequency of Spot-Forming Cells (SFC) per million splenocytes in samples from immunized animals (55p = 0.0137 and 56p = 0.0013) when compared to the other L3 peptides.",
            "startOffset": 34876,
            "title": "L3 immunodominant epitopes"
        },
        {
            "endOffset": 29244,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0075",
            "sentence": "A p value of 0.05 was considered significant.",
            "startOffset": 29199,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 35858,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 35857,
                    "startOffset": 35853
                }
            },
            "secId": "s0120",
            "sentence": "Currently, around 10 million individuals in the USA are immunocompromised, and live attenuated vaccines are contraindicated for them [22].",
            "startOffset": 35720,
            "title": "Discussion"
        },
        {
            "endOffset": 21390,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Plasmids were resuspended in purified water and stored at \u221220 \u00b0C until the day of immunization.",
            "startOffset": 21295,
            "title": "Plasmid propagation and purification"
        },
        {
            "endOffset": 24411,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Antigen-specific responses to IFN-\u03b3 and IL-4 were obtained after deducting the number of spots formed in the wells containing the RPMI alone from the spots developed in response to the L3 peptides.",
            "startOffset": 24214,
            "title": "IFN-\u03b3 and IL-4 ELISPOT"
        },
        {
            "endOffset": 29102,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0075",
            "sentence": "The statistical significance of the tests was determined using the Kruskal-Wallis nonparametric test followed by the Dunn\u2019s multiple comparisons test when the null model was rejected.",
            "startOffset": 28919,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 34875,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "From the 85 peptides that constituted the VVWR L3 protein sequence (Fig. 6), we observed a mean frequency of Spot-Forming Cells (SFC) per million splenocytes of 257.5 \u00b1 99.1 and 321.7 \u00b1 122.6, in splenocytes stimulated with peptides 55 (YRTNLPQSCYLNFIH) and 56 (LPQSCYLNFIHGHET), respectively.",
            "startOffset": 34582,
            "title": "L3 immunodominant epitopes"
        },
        {
            "endOffset": 19924,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 19850,
                    "startOffset": 19843
                },
                "b0065": {
                    "endOffset": 19850,
                    "startOffset": 19843
                },
                "b0070": {
                    "endOffset": 19850,
                    "startOffset": 19843
                }
            },
            "secId": "s0005",
            "sentence": "Serious adverse effects, including progressive vaccinia, autoinoculation, eczema vaccinatum, generalized vaccinia, congenital vaccinia, and post-vaccinial encephalitis [12\u201314] may occur after administration to an immunologically compromised patient.",
            "startOffset": 19675,
            "title": "Introduction"
        },
        {
            "endOffset": 29818,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "The capacity of L3 to induce a cell-mediated immune response was assessed by measuring the antigen-specific release of IFN-\u03b3 and IL-4 from mice splenocytes.",
            "startOffset": 29662,
            "title": "VVWR L3-specific IFN-\u03b3 and IL-4 responses"
        },
        {
            "endOffset": 35392,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "With this information, we describe a dominant epitope region of the L3 protein in our mouse model.",
            "startOffset": 35294,
            "title": "L3 immunodominant epitopes"
        },
        {
            "endOffset": 36905,
            "parents": [],
            "secId": "s0120",
            "sentence": "These results are similar to the ones obtained from the cytokine ELISA.",
            "startOffset": 36834,
            "title": "Discussion"
        },
        {
            "endOffset": 38758,
            "parents": [],
            "secId": "s0120",
            "sentence": "This information presents the first step for developing an epitope-based vaccine containing the L3 T-cell dominant epitopes.",
            "startOffset": 38634,
            "title": "Discussion"
        },
        {
            "endOffset": 21032,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Additionally, our clone has an immunoglobulin E (IgE) leader sequence, a Kozak consensus sequence, and a hemagglutinin (HA) tag (S1 File).",
            "startOffset": 20894,
            "title": "Design of the VVWR L3 DNA vaccine"
        },
        {
            "endOffset": 20034,
            "parents": [],
            "secId": "s0005",
            "sentence": "For these reasons, there is an increasing need to develop safer approaches that can benefit every individual.",
            "startOffset": 19925,
            "title": "Introduction"
        },
        {
            "endOffset": 33699,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0110",
            "sentence": "Meanwhile, IgG1 levels in pL3L-immunized animals were also higher than control groups.",
            "startOffset": 33613,
            "title": "Antibody isotyping"
        },
        {
            "endOffset": 28351,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "The reaction was stopped using 50 \u03bcL of 3 M HCl.",
            "startOffset": 28303,
            "title": "Total IgG and antibody isotyping ELISA"
        },
        {
            "endOffset": 32551,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "These results correlate with the ones obtained from our ELISPOT, demonstrating that our formulation promotes a robust IFN-\u03b3 response.",
            "startOffset": 32418,
            "title": "Cytokine concentration in cell supernatant"
        },
        {
            "endOffset": 37693,
            "parents": [],
            "secId": "s0120",
            "sentence": "This information establishes the important role of the CTL subset in the recovery from poxviral infections.",
            "startOffset": 37586,
            "title": "Discussion"
        },
        {
            "endOffset": 27141,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 27140,
                    "startOffset": 27136
                }
            },
            "secId": "s0060",
            "sentence": "These ex vivo results were confirmed with the in silico identification of the dominant regions, using the computer algorithm from the BioInformatics and Molecular Analysis Section (BIMAS) of the Center for Information Technology from the NIH [18].",
            "startOffset": 26894,
            "title": "L3 immunodominant epitopes"
        },
        {
            "endOffset": 31709,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "After depletion, there was an 83.9% decrease of the CD8+ T cell population (ANOVA test, KWT = 7.26, p = 0.0211) (Fig. 2B).",
            "startOffset": 31587,
            "title": "Contribution of CD8+ T cells in IFN-\u03b3 production"
        },
        {
            "endOffset": 29520,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Enzymatic digestion using XhoI and BamHI and agarose electrophoresis separation showed the expected 1.1 Kbp band (Fig. S1).",
            "startOffset": 29397,
            "title": "Restriction enzyme digestion of pL3L"
        },
        {
            "endOffset": 22147,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "All animal tests were carried out according to the protocol [9250112], including efforts to minimize suffering of animals under study.",
            "startOffset": 22013,
            "title": "Mice"
        },
        {
            "endOffset": 29974,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Pools of splenocytes from each immunized group were stimulated with an overlapping-peptide mix that represents the whole sequence of the VACVWR L3 protein.",
            "startOffset": 29819,
            "title": "VVWR L3-specific IFN-\u03b3 and IL-4 responses"
        },
        {
            "endOffset": 36094,
            "parents": [],
            "secId": "s0120",
            "sentence": "For these reasons, it is very important to create a new formulation that can be suitable for everyone.",
            "startOffset": 35992,
            "title": "Discussion"
        },
        {
            "endOffset": 33352,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0110",
            "sentence": "For this purpose, we used a secondary murine anti-IgG1 or IgG2a antibodies, with the same parameters employed to assess total IgG.",
            "startOffset": 33222,
            "title": "Antibody isotyping"
        },
        {
            "endOffset": 21713,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Confirmation of sequence assembly was assessed using the bioinformatics software MacVector (Cary, NC, USA).",
            "startOffset": 21606,
            "title": "Plasmid propagation and purification"
        },
        {
            "endOffset": 36598,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 36597,
                    "startOffset": 36593
                }
            },
            "secId": "s0120",
            "sentence": "Meanwhile, IL-4 polarizes the response towards a TH-2 type [25].",
            "startOffset": 36534,
            "title": "Discussion"
        },
        {
            "endOffset": 36833,
            "parents": [],
            "secId": "s0120",
            "sentence": "The scenario was different when assessing the IL-4 response, as no variation among the three groups was observed.",
            "startOffset": 36720,
            "title": "Discussion"
        },
        {
            "endOffset": 20319,
            "parents": [],
            "secId": "s0005",
            "sentence": "Therefore, we expect this antigen to promote cross-protection.",
            "startOffset": 20257,
            "title": "Introduction"
        },
        {
            "endOffset": 27475,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Briefly, 50 \u03bcg of L3 antigenic protein was dissolved in 50 mM carbonate buffer to coat Maxisorp (Millipore, Bedford, MA, USA) plates.",
            "startOffset": 27342,
            "title": "Total IgG and antibody isotyping ELISA"
        },
        {
            "endOffset": 24803,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Briefly, mouse spleen cells were incubated with CD8a (Ly-2) MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany).",
            "startOffset": 24686,
            "title": "CD8+ cell depletion"
        },
        {
            "endOffset": 18780,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 18683,
                    "startOffset": 18680
                },
                "b0010": {
                    "endOffset": 18737,
                    "startOffset": 18734
                },
                "b0015": {
                    "endOffset": 18779,
                    "startOffset": 18776
                }
            },
            "secId": "s0005",
            "sentence": "They consist of double stranded DNA [1] with genomes ranging from 130 to 360 kb in length [2] encoding over 200 open reading frames [3].",
            "startOffset": 18644,
            "title": "Introduction"
        },
        {
            "endOffset": 22012,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Maintenance of the animals was in accordance with the guidelines from The National Institutes of Health (Bethesda, MD, USA), and the University of Puerto Rico Institutional Care and Use Committee (IACUC).",
            "startOffset": 21808,
            "title": "Mice"
        },
        {
            "endOffset": 22926,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "These were manufactured as both: a) individual peptides for epitope mapping and b) peptide pool.",
            "startOffset": 22830,
            "title": "Synthetic peptides"
        },
        {
            "endOffset": 38483,
            "parents": [],
            "secId": "s0120",
            "sentence": "Lastly, we performed dominant L3-epitope mapping with individual, overlapping peptides encompassing the entire L3 protein.",
            "startOffset": 38361,
            "title": "Discussion"
        },
        {
            "endOffset": 25510,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Cells were harvested by centrifugation at 887 x g for 1 min at 4 \u00b0C.",
            "startOffset": 25442,
            "title": "Flow cytometry analysis"
        },
        {
            "endOffset": 23962,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Spot development was assessed after the additon of 5-Bromo-4-Chloro-3\u2032 Indolylphosphate p-Toluidine Salt (BCIP) and Nitro Blue Tetrazololium Chloride (NBT) (R&D Systems, Minneapolis, MN).",
            "startOffset": 23775,
            "title": "IFN-\u03b3 and IL-4 ELISPOT"
        },
        {
            "endOffset": 32709,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0105",
            "sentence": "To further examine the immunogenicity of this novel poxviral protein, we analyzed serum samples by indirect ELISA.",
            "startOffset": 32595,
            "title": "Activation of the humoral immune response"
        },
        {
            "endOffset": 32865,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0105",
            "sentence": "The purpose of these experiments was to determine if immunization with a plasmid coding for L3 can activate antibody immunity in our animal model (Fig. 4).",
            "startOffset": 32710,
            "title": "Activation of the humoral immune response"
        },
        {
            "endOffset": 38361,
            "parents": [],
            "secId": "s0120",
            "sentence": "Additionally, IgG isotype analysis shows that both, IgG2a and IgG1 levels are increased after pL3L administration.",
            "startOffset": 38247,
            "title": "Discussion"
        },
        {
            "endOffset": 18841,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 18840,
                    "startOffset": 18837
                }
            },
            "secId": "s0005",
            "sentence": "Their complex brick-shaped capsids are about 240\u2013300 nm [4].",
            "startOffset": 18781,
            "title": "Introduction"
        },
        {
            "endOffset": 26131,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Results from IFN-\u03b3 and IL-4 ELISPOT assays were validated by evaluating the cytokine profile in the cell culture supernatant.",
            "startOffset": 26006,
            "title": "Cytokine concentration in cell supernatant"
        },
        {
            "endOffset": 19554,
            "parents": [],
            "secId": "s0005",
            "sentence": "To prevent smallpox infection, there is only a prophylactic vaccine approved by the Federal Drug Administration (FDA).",
            "startOffset": 19436,
            "title": "Introduction"
        },
        {
            "endOffset": 24685,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Pools of splenocytes from individual groups were incubated with anti-mouse-CD8+ antibodies and separated as recommended by the manufacturer's instructions using the autoMACS magnetic cell separation system (Miltenyi Biotec, Bergisch Gladbach, Germany).",
            "startOffset": 24433,
            "title": "CD8+ cell depletion"
        },
        {
            "endOffset": 30840,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "These data demonstrate that administration of L3 as naked DNA promotes antigen-specific IFN-\u03b3 secretion.",
            "startOffset": 30736,
            "title": "VVWR L3-specific IFN-\u03b3 and IL-4 responses"
        },
        {
            "endOffset": 35534,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 35533,
                    "startOffset": 35527
                },
                "b0095": {
                    "endOffset": 35533,
                    "startOffset": 35527
                }
            },
            "secId": "s0120",
            "sentence": "Zoonotic poxviruses represent a serious health threat, and the number of reported cases has been increasing in recent years [6,19].",
            "startOffset": 35403,
            "title": "Discussion"
        },
        {
            "endOffset": 38152,
            "parents": [],
            "refoffsets": {
                "b0150": {
                    "endOffset": 38151,
                    "startOffset": 38147
                }
            },
            "secId": "s0120",
            "sentence": "IgG is the most abundant immunoglobulin in serum and has the capacity to neutralize viral particles, activate complement, and promote phagocytosis by opsonization [30].",
            "startOffset": 37984,
            "title": "Discussion"
        },
        {
            "endOffset": 24923,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "After incubation, cells were washed with 2 mL of buffer (0.25% BSA, 0.5 M EDTA), and centrifuged at 300 \u00d7 g for 10 min.",
            "startOffset": 24804,
            "title": "CD8+ cell depletion"
        },
        {
            "endOffset": 26298,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 26297,
                    "startOffset": 26293
                }
            },
            "secId": "s0055",
            "sentence": "For this purpose, we used the Quantikine Mouse IFN-\u03b3, and IL-4 sandwich immunoassays (R&D Systems, Minneapolis, USA) following a previously established protocol [17].",
            "startOffset": 26132,
            "title": "Cytokine concentration in cell supernatant"
        },
        {
            "endOffset": 27276,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Humoral immune responses were assessed by indirect Enzyme-Linked Immunosorbent Assay (ELISA).",
            "startOffset": 27183,
            "title": "Total IgG and antibody isotyping ELISA"
        },
        {
            "endOffset": 28538,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0070",
            "sentence": "All protocols for mice experiments were reviewed and approved by the University of Puerto Rico Institutional Care and Use Committee (IACUC) (9250112).",
            "startOffset": 28388,
            "title": "Compliance with ethical standards"
        },
        {
            "endOffset": 24131,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "An automated ELISPOT reader system (CTL analyzers, Cleveland OH, USA) was used for spot quantification using the ImmunoSpot software (CTL analyzers, Cleveland OH, USA).",
            "startOffset": 23963,
            "title": "IFN-\u03b3 and IL-4 ELISPOT"
        },
        {
            "endOffset": 28918,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0075",
            "sentence": "The results are presented as the average \u00b1 standard error of the mean (SEM) using GraphPad Prism, version 7.02 (San Diego, CA, USA) for all analyses.",
            "startOffset": 28769,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 30195,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Our data shows that immunization with pL3L induces an extremely significant increase in the production of IFN-\u03b3 when compared to controls.",
            "startOffset": 30057,
            "title": "VVWR L3-specific IFN-\u03b3 and IL-4 responses"
        },
        {
            "endOffset": 20753,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The L3L gene from Vaccinia Virus Western Reserve (VVWR) used in this study was synthesized by BlueHeronBio (Bothell, WA, USA), and cloned into the pVax1 (Invitrogen, Grand Island, NY, USA) BamHI and XhoI (New England Biolabs, Ipswich, MA, USA) restriction sites, to generate the vaccine construct (pL3L).",
            "startOffset": 20449,
            "title": "Design of the VVWR L3 DNA vaccine"
        },
        {
            "endOffset": 33865,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0110",
            "sentence": "Means corresponding to na\u00efve, pVAX1 and pL3L were as follows: 0.0567 \u00b1 0.001324, 0.0553 \u00b1 0.0008 and 0.0852 \u00b1 0.00635 (ANOVA test, KWT = 17.09, p = 0.002) (Fig. 5B).",
            "startOffset": 33700,
            "title": "Antibody isotyping"
        },
        {
            "endOffset": 26700,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Fragments that produced a positive signal were identified by the appearance of spots in its ELISPOT well.",
            "startOffset": 26595,
            "title": "L3 immunodominant epitopes"
        },
        {
            "endOffset": 22624,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Blood samples and spleens were collected one week after the last immunization.",
            "startOffset": 22546,
            "title": "Study design"
        },
        {
            "endOffset": 25093,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Flow cytometry analysis was performed before and after cell removal.",
            "startOffset": 25025,
            "title": "Flow cytometry analysis"
        },
        {
            "endOffset": 32417,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "Furthermore, IL-4 levels were similar in all groups, showing no statistical significance among them (ANOVA test, KWT = 2.489, p = 0.3393) (Fig. 3B).",
            "startOffset": 32269,
            "title": "Cytokine concentration in cell supernatant"
        },
        {
            "endOffset": 38246,
            "parents": [],
            "secId": "s0120",
            "sentence": "Our ELISA shows that mice receiving pL3L have a significant increase in total IgG production.",
            "startOffset": 38153,
            "title": "Discussion"
        },
        {
            "endOffset": 25644,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Afterwards, pellets were resuspended in 100\u03bcL FACS staining buffer (0.5 mM EDTA, 0.05% FBS, 1X PBS) containing the antibody cocktail.",
            "startOffset": 25511,
            "title": "Flow cytometry analysis"
        },
        {
            "endOffset": 35719,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 35617,
                    "startOffset": 35610
                },
                "b0105": {
                    "endOffset": 35617,
                    "startOffset": 35610
                }
            },
            "secId": "s0120",
            "sentence": "Even though ACAM2000 has demonstrated to be an extremely effective vaccine [20,21], the formulation can cause serious health complications, especially in immunocompromised individuals.",
            "startOffset": 35535,
            "title": "Discussion"
        },
        {
            "endOffset": 19009,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 19008,
                    "startOffset": 19005
                }
            },
            "secId": "s0005",
            "sentence": "They are the only known viruses that can replicate entirely in the cytoplasm, as they possess the essential viral biosynthetic machinery for DNA and RNA synthesis [5].",
            "startOffset": 18842,
            "title": "Introduction"
        },
        {
            "endOffset": 33221,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0110",
            "sentence": "Next, we wanted to determine which IgG isotype was predominant.",
            "startOffset": 33158,
            "title": "Antibody isotyping"
        },
        {
            "endOffset": 19674,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 19673,
                    "startOffset": 19669
                }
            },
            "secId": "s0005",
            "sentence": "Its formulation is based on a live-vaccinia virus and thus is contraindicated for a large group of the population [11].",
            "startOffset": 19555,
            "title": "Introduction"
        },
        {
            "endOffset": 20106,
            "parents": [],
            "secId": "s0005",
            "sentence": "In the present study, we focus on the L3L open reading frame (VACWR090).",
            "startOffset": 20034,
            "title": "Introduction"
        },
        {
            "endOffset": 37309,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 37275,
                    "startOffset": 37271
                },
                "b0135": {
                    "endOffset": 37308,
                    "startOffset": 37304
                }
            },
            "secId": "s0120",
            "sentence": "It has been well recognized that CD8+ T-lymphocytes are crucial for immune control of viral replication [26] and HIV viral load decrease [27].",
            "startOffset": 37167,
            "title": "Discussion"
        },
        {
            "endOffset": 28302,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Chemiluminescence produced by the secondary antibody was measured at 450 nm using a plate reader after addition of OPD peroxidase substrate (Sigma Aldrich, St. Louis, MO, USA).",
            "startOffset": 28126,
            "title": "Total IgG and antibody isotyping ELISA"
        },
        {
            "endOffset": 33613,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0110",
            "sentence": "Our results show that IgG2a (Th-1 type associated antibody) was significantly higher in pL3L immunized animals, 0.5632 \u00b1 0.0856 versus 0.0661 \u00b1 0.0061 and 0.1135 \u00b1 0.0130 for na\u00efve and pVAX1 groups, respectively (ANOVA test, KWT = 20.64, p < 0.0001) (Fig. 5A).",
            "startOffset": 33353,
            "title": "Antibody isotyping"
        },
        {
            "endOffset": 33966,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0110",
            "sentence": "These results demonstrate that our formulation up-regulates the production of both soluble isoforms.",
            "startOffset": 33866,
            "title": "Antibody isotyping"
        },
        {
            "endOffset": 22239,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "All groups consisted of four mice, and all experiments were performed at least three times.",
            "startOffset": 22148,
            "title": "Mice"
        },
        {
            "endOffset": 23774,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "After stimulation, plates were washed and incubated overnight at 4 \u00b0C with biotinylated anti-mouse IFN-\u03b3 or IL-4 antibodies.",
            "startOffset": 23650,
            "title": "IFN-\u03b3 and IL-4 ELISPOT"
        },
        {
            "endOffset": 24213,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The mean number of spots from triplicate wells was adjusted to 1x106 splenocytes.",
            "startOffset": 24132,
            "title": "IFN-\u03b3 and IL-4 ELISPOT"
        },
        {
            "endOffset": 31432,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "Flow cytometry analysis was performed in both samples to determine the percentage of CD8+ cells before and after separation.",
            "startOffset": 31308,
            "title": "Contribution of CD8+ T cells in IFN-\u03b3 production"
        },
        {
            "endOffset": 34483,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "We stimulated pools of splenocytes isolated from immunized mice with individual overlapping peptides corresponding to L3 protein.",
            "startOffset": 34354,
            "title": "L3 immunodominant epitopes"
        },
        {
            "endOffset": 27531,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "After overnight incubation at 4 \u00b0C, plates were washed.",
            "startOffset": 27476,
            "title": "Total IgG and antibody isotyping ELISA"
        },
        {
            "endOffset": 19117,
            "parents": [],
            "secId": "s0005",
            "sentence": "Variola, Monkeypox, Cowpox, and Molluscum contagiosum viruses are among the known human pathogenic members.",
            "startOffset": 19010,
            "title": "Introduction"
        },
        {
            "endOffset": 23265,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Capture anti-murine IFN-\u03b3 or IL-4 antibodies (R&D Systems, Minneapolis, MN, USA) were individually coated by overnight incubation at 4 \u00b0C onto High-Protein Binding IP 96-well Multiscreen TM plates (Millipore, Bedford, MA, USA).",
            "startOffset": 23038,
            "title": "IFN-\u03b3 and IL-4 ELISPOT"
        },
        {
            "endOffset": 27341,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Total IgG, and antibody isotypes were measured from mouse serum.",
            "startOffset": 27277,
            "title": "Total IgG and antibody isotyping ELISA"
        },
        {
            "endOffset": 27670,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "To avoid unspecific interactions, wells were blocked with ChonBlock Buffer (Chondrex, Redmond, WA, USA) for two hours at room temperature.",
            "startOffset": 27532,
            "title": "Total IgG and antibody isotyping ELISA"
        },
        {
            "endOffset": 36719,
            "parents": [],
            "secId": "s0120",
            "sentence": "In this regard, our IFN-\u03b3 ELISPOT demonstrates that pL3L dramatically stimulates antigen-specific IFN-\u03b3 producing cells.",
            "startOffset": 36599,
            "title": "Discussion"
        },
        {
            "endOffset": 32269,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "Our data shows that mice immunized with pL3L produced 630.4 \u00b1 205.7 pg/ml of IFN-\u03b3 versus 306.4 \u00b1 113.9, and 89.14 \u00b1 22.33 pg/ml in pVAX1 and na\u00efve groups, respectively (ANOVA test, KWT = 7.678, p = 0.0215) (Fig. 3A).",
            "startOffset": 32052,
            "title": "Cytokine concentration in cell supernatant"
        },
        {
            "endOffset": 29350,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0075",
            "sentence": "For all figures, p values are noted as p < 0.05 (\u2217), p < 0.01 (\u2217\u2217), p < 0.001 (\u2217\u2217\u2217) or p < 0.0001 (\u2217\u2217\u2217\u2217).",
            "startOffset": 29245,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 22545,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Animals were immunized in the quadriceps with 100 \u00b5g of the plasmids, three times by intramuscular (i.m.) injection with a 27-gauge sterile needle, at two-week intervals.",
            "startOffset": 22375,
            "title": "Study design"
        },
        {
            "endOffset": 33137,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0105",
            "sentence": "Our results show that the production of total IgG (0.9274 \u00b1 0.1163) increased 8.4- and a 2.6-times in animals that received pL3L, compared to na\u00efve (0.111 \u00b1 0.01274) and backbone vector (0.3599 \u00b1 0.03356) control groups, respectively (ANOVA test, KWT = 33.31, p < 0.0001).",
            "startOffset": 32865,
            "title": "Activation of the humoral immune response"
        },
        {
            "endOffset": 34581,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "The frequencies of SFC per million splenocytes producing IFN-\u03b3 were measured by ELISPOT analysis.",
            "startOffset": 34484,
            "title": "L3 immunodominant epitopes"
        },
        {
            "endOffset": 31586,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "Our results showed that 57.5 \u00b1 2.03 percent of the cells isolated from mice spleen were T-lymphocytes (CD3+), from which 31.07 \u00b1 1.27% were CD8+ T cells.",
            "startOffset": 31433,
            "title": "Contribution of CD8+ T cells in IFN-\u03b3 production"
        },
        {
            "endOffset": 20893,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The plasmid also contains a kanamycin resistance gene, a BGH polyadenylation signal, and is under a cytomegalovirus promoter (CMV) control.",
            "startOffset": 20754,
            "title": "Design of the VVWR L3 DNA vaccine"
        },
        {
            "endOffset": 26412,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Sample values were correlated to a standard curve.",
            "startOffset": 26362,
            "title": "Cytokine concentration in cell supernatant"
        },
        {
            "endOffset": 36390,
            "parents": [],
            "secId": "s0120",
            "sentence": "We tested the ability of our formulation to induce antigen-specific cytokine production.",
            "startOffset": 36302,
            "title": "Discussion"
        },
        {
            "endOffset": 37424,
            "parents": [],
            "refoffsets": {
                "b0140": {
                    "endOffset": 37423,
                    "startOffset": 37419
                }
            },
            "secId": "s0120",
            "sentence": "This is also true during Ectromelia virus infection, as mice lacking CD8+ T cells have a 100% mortality rate [28].",
            "startOffset": 37310,
            "title": "Discussion"
        },
        {
            "endOffset": 30056,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Frequency of L3-specific IFN-\u03b3 or IL-4 producing cells was determined by ELISPOT.",
            "startOffset": 29975,
            "title": "VVWR L3-specific IFN-\u03b3 and IL-4 responses"
        },
        {
            "endOffset": 38633,
            "parents": [],
            "secId": "s0120",
            "sentence": "Our analysis revealed that the region NLPQSCYL, is contained among two out of eighty-five individual peptides promoting significant release of IFN-\u03b3.",
            "startOffset": 38484,
            "title": "Discussion"
        },
        {
            "endOffset": 38882,
            "parents": [],
            "secId": "s0120",
            "sentence": "Our study demonstrates that this novel poxviral protein can induce both humoral- and cell-mediated immune responses in mice.",
            "startOffset": 38758,
            "title": "Discussion"
        },
        {
            "endOffset": 38990,
            "parents": [],
            "secId": "s0120",
            "sentence": "Our data suggests that L3 could be a promising antigen for vaccine development against poxviral infections.",
            "startOffset": 38883,
            "title": "Discussion"
        },
        {
            "endOffset": 34353,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "Once we demonstrated that a plasmid coding for the VACVWR L3 protein induced a cell-mediated immune response using a mixture of overlapping peptides, we decided to identify immunodominant regions, using the same immunization scheme.",
            "startOffset": 34121,
            "title": "L3 immunodominant epitopes"
        },
        {
            "endOffset": 19436,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 19346,
                    "startOffset": 19341
                },
                "b0035": {
                    "endOffset": 19346,
                    "startOffset": 19341
                },
                "b0040": {
                    "endOffset": 19376,
                    "startOffset": 19373
                },
                "b0045": {
                    "endOffset": 19401,
                    "startOffset": 19398
                },
                "b0050": {
                    "endOffset": 19435,
                    "startOffset": 19431
                }
            },
            "secId": "s0005",
            "sentence": "Poxviruses can be transmitted by zoonosis [6], contaminated fomites or objects, from person to person via air droplets [6,7], direct contact with rash [8], sexual transmission [9] and the transplacental route [10].",
            "startOffset": 19222,
            "title": "Introduction"
        },
        {
            "endOffset": 24999,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Pellets were resuspended in buffer and samples were loaded in the autoMACS.",
            "startOffset": 24924,
            "title": "CD8+ cell depletion"
        },
        {
            "endOffset": 32051,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "IFN-\u03b3 and IL-4 ELISPOT results were confirmed by measuring the concentration of these cytokines in supernatant of cultured mice splenocytes by ELISA.",
            "startOffset": 31902,
            "title": "Cytokine concentration in cell supernatant"
        },
        {
            "endOffset": 37166,
            "parents": [],
            "secId": "s0120",
            "sentence": "Flow cytometry analysis indicated that we obtained 83.9% of depletion, leading to an 81.5% reduction in peptide-induced IFN-\u03b3 (Fig. 3B).",
            "startOffset": 37030,
            "title": "Discussion"
        },
        {
            "endOffset": 31070,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "Our CD8+ T-cell depletion assay revealed a significant decrease in the frequency of IFN-\u03b3 producing cells after CD8+ cell removal, compared to the non-depleted fraction (Fig. 2A).",
            "startOffset": 30891,
            "title": "Contribution of CD8+ T cells in IFN-\u03b3 production"
        }
    ],
    "docId": "S0264410X1830207X",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "mayte.ramirez@upr.edu",
                "first": "Maite",
                "initial": "M.",
                "last": "Ram\u00edrez"
            },
            {
                "email": "saritza.santos@upr.edu",
                "first": "Saritza",
                "initial": "S.",
                "last": "Santos"
            },
            {
                "email": "osmarie.martinez@upr.edu",
                "first": "Osmarie",
                "initial": "O.",
                "last": "Mart\u00ednez"
            },
            {
                "email": "ricardo.rodriguez44@upr.edu",
                "first": "Ricardo",
                "initial": "R.",
                "last": "Rodr\u00edguez"
            },
            {
                "email": "eric.miranda@upr.edu",
                "first": "Eric",
                "initial": "E.",
                "last": "Miranda"
            },
            {
                "email": "willy.ramos@upr.edu",
                "first": "Willy D.",
                "initial": "W.D.",
                "last": "Ramos-Perez"
            },
            {
                "email": "miguel.otero2@upr.edu",
                "first": "Miguel",
                "initial": "M.",
                "last": "Otero"
            }
        ],
        "doi": "10.1016/j.vaccine.2018.02.033",
        "firstpage": "2049",
        "issn": "0264410X",
        "keywords": [
            "Bioterror agents",
            "DNA-vaccine",
            "L3L",
            "Novel antigen",
            "Smallpox",
            "Vaccine"
        ],
        "lastpage": "2055",
        "openaccess": "Full",
        "pub_year": 2018,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA"
    }
}